Cardiovascular stents: overview, evolution, and next generation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abizaid A et al (2004) First human experience with the 17-beta-estradiol-eluting stent. J Am Coll Cardiol 43:1118–1121
Abizaid A et al (2007) Randomized, double-blind, multicenter study of the polymer-based 17-β estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial. Catheter Cardiovasc Interv 70:654–660
Abizaid A et al (2015) The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention 10:1396–1401
Acharya G, Park K (2006) Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 58:387–401
Adil D (1999) Heparin-immobolized poly (2-hydroxyethylmethacrylate)-based microspheres. J Appl Sci 74:655–662
Ahmed M (2011) Design and development of a prosthetic implant for cardiovascular reconstructions. Doctoral dissertation, University College London
Airoldi F et al (2005) 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease. Am J Cardiol 96:664–667
Ajili SH (2008) Preparation, study and modeling of polyurethane/polycaprolactone blend with shape memory effect in the range of body temperature. Doctoral dissertation, Tarbiat Modares University
Ajili SH, Ebrahimi NG, Soleimani M (2009) Polyurethane/polycaprolactane blend with shape memory effect as a proposed material for cardiovascular implants. Acta Biomater 5:1519–1530
Alexander GC, Hwang PT, Chen J, J-a Kim, Brott BC, Yoon Y-S, Jun H-W (2017) Nanomatrix coated stent enhances endothelialization but reduces platelet, smooth muscle cell, and monocyte adhesion under physiologic conditions. ACS Biomater Sci Eng 4:107–115
Alviar CL et al (2012) Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis 34:91–98
Anastasiou TJ, Uhrich KE (2000) Novel polyanhydrides with enhanced thermal and solubility properties. Macromolecules 33:6217–6221
Andrianov AK, Payne LG, Visscher KB, Allcock HR, Langer R (1994) Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres. J Appl Polym Sci 53:1573–1578
Babapulle MN, Eisenberg MJ (2002a) Coated stents for the prevention of restenosis: part I. Circulation 106:2734–2740
Babapulle MN, Eisenberg MJ (2002b) Coated stents for the prevention of restenosis: part II. Circulation 106:2859–2866
Balakrishnan B, Dooley JF, Kopia G, Edelman ER (2007) Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release 123:100–108
Basalus M, Ankone M, Van Houwelingen G, De Man F, von Birgelen C (2009) Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention 5:157–165
Basalus MW et al (2012) Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents. Catheter Cardiovasc Interv 79:644–653
Bergström JS, Hayman D (2016) An overview of mechanical properties and material modeling of polylactide (PLA) for medical applications. Ann Biomed Eng 44:330–340
Bourantas CV, Onuma Y, Farooq V, Zhang Y, Garcia-Garcia HM, Serruys PW (2013) Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol 167:11–21
Bozsak F, Chomaz J-M, Barakat AI (2014) Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall. Biomech Model Mechanobiol 13:327–347
Brugaletta S et al (2012) Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. Circ J 76:1616–1623
Busch R et al (2014) New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Acta Biomater 10:688–700
Capodanno D et al (2015) Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 10:1144–1153
Celermajer DS (1997) Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 30:325–333
Chaloupka K, Motwani M, Seifalian AM (2011) Development of a new lacrimal drainage conduit using POSS nanocomposite. Biotechnol Appl Biochem 58:363–370
Chen M-C et al (2007) Rapidly self-expandable polymeric stents with a shape-memory property. Biomacromol 8:2774–2780
Chen W, Habraken TC, Hennink WE, Kok RJ (2015) Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents. Bioconjug Chem 26:1277–1288
Chow AH, Tong HH, Chattopadhyay P, Shekunov BY (2007) Particle engineering for pulmonary drug delivery. Pharm Res 24:411–437
Costa JR et al (2009) 1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial. JACC 2:422–427
Dang TT, Nikkhah M, Memic A, Khademhosseini A (2014) Chapter 19—Polymeric Biomaterials for Implantable Prostheses A2—Kumbar, Sangamesh G. In: Laurencin CT, Deng M (eds) Natural and synthetic biomedical polymers. Elsevier, Oxford, pp 309–331. https://doi.org/10.1016/B978-0-12-396983-5.00020-X
Driver M (2012) 7—Coatings for cardiovascular devices: coronary stents. In: Coatings for biomedical applications. Woodhead Publishing, Sawston, pp 223–250
Ertel SI, Kohn J (1994) Evaluation of a series of tyrosine-derived polycarbonates as degradable biomaterials. J Biomed Mater Res Part A 28:919–930
Eyring H (1936) Viscosity, plasticity, and diffusion as examples of absolute reaction rates. J Chem Phys 4:283–291
Farah S (2018) Protective layer development for enhancing stability and drug-delivery capabilities of des surface-crystallized coatings. ACS Appl Mater Interfaces 10:9010–9022
Farb A, Burke AP, Kolodgie FD, Virmani R (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108:1701–1706
Ferns GA, Avades TY (2000) The mechanisms of coronary restenosis: insights from experimental models. Int J Exp Pathol 81:63–88
Fiordeliso J, Bron S, Kohn J (1994) Design, synthesis, and pr eliminary characterization of tyrosine-containing polyarylates: new biomaterials for medical applications. J Biomater Sci Polymer Edition 5:496–510
Fischman DL et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331:496–501
Franz S, Rammelt S, Scharnweber D, Simon JC (2011) Immune responses to implants—a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32:6692–6709
Gada H et al (2013) 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC 6:1263–1266
Gallo A, Mani G (2013) A stent for co-delivering paclitaxel and nitric oxide from abluminal and luminal surfaces: preparation, surface characterization, and in vitro drug release studies. Appl Surf Sci 279:216–232
Generali M, Dijkman PE, Hoerstrup SP (2014) Bioresorbable scaffolds for cardiovascular tissue engineering. Eur Med J Interv Cardiol 1:91–99
Gijsen FJ et al (2003) Usefulness of shear stress pattern in predicting neointima distribution in sirolimus-eluting stents in coronary arteries. Am J Cardiol 92:1325–1328
Gomez-Lara J et al (2010) A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. JACC 3:1190–1198
Gomez-Lara J et al (2011) Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up. JACC 4:789–799
Grabow N, Martin DP, Schmitz KP, Sternberg K (2010) Absorbable polymer stent technologies for vascular regeneration. J Chem Technol Biotechnol 85:744–751
Grijpma DW, Pennings AJ (1994) (Co) polymers of l-lactide, 2. Mechanical properties. Macromol Chem Phys 195:1649–1663
Grüntzig A (1978) Transluminal dilatation of coronary artery stenosis—experimental report. In: Percutaneous vascular recanalization. Springer, Berlin, Heidelberg, pp 57–65
Guildford A, Santin M, Phillips GJ (2010) 7—Cardiovascular stents A2—Gourlay, terence. In: Black RA (ed) Biomaterials and devices for the circulatory system. Woodhead Publishing, Sawston, pp 173–216. https://doi.org/10.1533/9780857090553.2.173
Gyöngyösi M, Yang P, Khorsand A, Glogar D, Group AWSS, Investigators EPS (2000) Longitudinal straightening effect of stents is an additional predictor for major adverse cardiac events. J Am Coll Cardiol 35:1580–1589
Hara H, Nakamura M, Palmaz JC, Schwartz RS (2006) Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev 58:377–386
Hårdhammar PA et al (1996) Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93:423–430
Haude M et al (2016a) Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. EuroIntervention 12:e160–e166
Haude M et al (2016b) Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. Lancet 387:31–39
Hayman D, Bergerson C, Miller S, Moreno M, Moore JE (2014) The effect of static and dynamic loading on degradation of PLLA stent fibers. J Biomech Eng 136:081006
Hemshekhar M, Thushara RM, Chandranayaka S, Sherman LS, Kemparaju K, Girish KS (2016) Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine. Int J Biol Macromol 86:917–928
Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A (2003) Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 89:651–656
Hornberger H, Virtanen S, Boccaccini A (2012) Biomedical coatings on magnesium alloys—a review. Acta Biomater 8:2442–2455
Hsiao H-M, Chiu Y-H, Wu T-Y, Shen J-K, Lee T-Y (2013) Effects of through-hole drug reservoirs on key clinical attributes for drug-eluting depot stent. Med Eng Phys 35:884–897
Hu T et al (2015) Controlled slow-release drug-eluting stents for the prevention of coronary restenosis: recent progress and future prospects. ACS Appl Mater Interfaces 7:11695–11712
Huang Y et al (2010) In vitro and in vivo performance of a dual drug-eluting stent (DDES). Biomaterials 31:4382–4391
Hwang C-W, Wu D, Edelman ER (2001) Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104:600–605
Ibim SE, Ambrosio AM, Kwon MS, El-Amin SF, Allcock HR, Laurencin CT (1997) Novel polyphosphazene/poly (lactide-co-glycolide) blends: miscibility and degradation studies. Biomaterials 18:1565–1569
Iqbal J, Onuma Y, Ormiston J, Abizaid A, Waksman R, Serruys P (2013) Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J 35:765–776
Jain RA (2000) The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials 21:2475–2490
Jiang W, Tian Q, Vuong T, Shashaty M, Gopez C, Sanders T, Liu H (2017) Comparison study on four biodegradable polymer coatings for controlling magnesium degradation and human endothelial cell adhesion and spreading. ACS Biomater Sci Eng 3:936–950
Johnson I, Akari K, Liu H (2013) Nanostructured hydroxyapatite/poly (lactic-co-glycolic acid) composite coating for controlling magnesium degradation in simulated body fluid. Nanotechnology 24:375103
Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozoky B, Crowley C, Einarsson O, Grinnemo KH, Gudbjartsson T et al (2011) Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 378:1997–2004
Kakade S, Mani G (2013) A comparative study of the effects of vitamin C, sirolimus, and paclitaxel on the growth of endothelial and smooth muscle cells for cardiovascular medical device applications. Drug Design Dev Therapy 7:529
Kawamoto H et al (2015) Drug-coated balloons versus second-generation drug-eluting stents for the management of recurrent multimetal-layered in-stent restenosis. JACC 8:1586–1594
Kereiakes DJ, Onuma Y, Serruys PW, Stone GW (2016) Bioresorbable vascular scaffolds for coronary revascularization. Circulation 134:168–182
Khashi M, Hassanajili S, Golestaneh SM (2018) Electrospun poly-lactic acid/chitosan nanofibers loaded with paclitaxel for coating of a prototype polymeric stent. Fibers Polymers J 19(7):1444–1453
Kim JM et al (2015) A method for coating fucoidan onto bare metal stent and in vivo evaluation. Prog Org Coat 78:348–356
Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW (2015) A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J 36(47):3332–3342. https://doi.org/10.1093/eurheartj/ehv435
Kočka V, Toušek P, Widimský P (2015) Absorb bioresorbable stents for the treatment of coronary artery disease. Expert Rev Med Devices 12:545–557
Kohn J, Zeltinger J (2005) Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease. Expert Rev Med Devices 2:667–671
Kotsar A et al (2008) A new biodegradable braided self-expandable PLGA prostatic stent: an experimental study in the rabbit. J Endourol 22:1065–1070
Kraitzer A, Kloog Y, Zilberman M (2008) Approaches for prevention of restenosis. J Biomed Mater Res Part B 85:583–603
Lancaster S, Kakade S, Mani G (2012) Microrough cobalt–chromium alloy surfaces for paclitaxel delivery: preparation, characterization, and in vitro drug release studies. Langmuir 28:11511–11526
Langer R, Peppas NA (2003) Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J 49:2990–3006
Lanzer P, Sternberg K, Schmitz K-P, Kolodgie F, Nakazawa G, Virmani R (2008) Drug-eluting coronary stent very late thrombosis revisited. Herz 33:334–342
Lemmouchi Y, Schacht E, Dejardin S (1998) Biodegradable poly [(amino acid ester) phosphazenes] for biomedical applications. J Bioact Compat Polymers 13:4–18
Lendlein A, Langer R (2002) Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 296:1673–1676
Levy Y, Mandler D, Weinberger J, Domb AJ (2009a) Evaluation of drug-eluting stents’ coating durability—clinical and regulatory implications. J Biomed Mater Res Part B 91:441–451
Levy Y, Tal N, Tzemach G, Weinberger J, Domb AJ, Mandler D (2009b) Drug-eluting stent with improved durability and controllability properties, obtained via electrocoated adhesive promotion layer. J Biomed Mater Res Part B 91:819–830
Li QL et al (2009) Anticoagulant surface modification of titanium via layer-by-layer assembly of collagen and sulfated chitosan multilayers. J Biomed Mater Res Part A 89:575–584
Li J, Cao P, Zhang X, Zhang S, He Y (2010) In vitro degradation and cell attachment of a PLGA coated biodegradable Mg–6Zn based alloy. J Mater Sci 45:6038–6045
Li G, Yang P, Liao Y, Huang N (2011) Tailoring of the titanium surface by immobilization of heparin/fibronectin complexes for improving blood compatibility and endothelialization: an in vitro study. Biomacromol 12:1155–1168
Li J, Zhang K, Wu F, He Z, Yang P, Huang N (2015a) Constructing bio-functional layers of hyaluronan and type IV collagen on titanium surface for improving endothelialization. J Mater Sci 50:3226–3236
Li J, Zhang K, Wu J, Zhang L, Yang P, Tu Q, Huang N (2015b) Tailoring of the titanium surface by preparing cardiovascular endothelial extracellular matrix layer on the hyaluronic acid micro-pattern for improving biocompatibility. Colloids Surf B 128:201–210
Li J et al (2017) Controlling molecular weight of hyaluronic acid conjugated on amine-rich surface: toward better multifunctional biomaterials for cardiovascular implants. ACS Appl Mater Interfaces 9:30343–30358
Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ (1997) Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 29:808–816
Liu Q, Zhang J, Sun W, Xie QR, Xia W, Gu H (2012) Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells. Int J Nanomed 7:999
Liu T et al (2014) Surface modification with dopamine and heparin/poly-l-lysine nanoparticles provides a favorable release behavior for the healing of vascular stent lesions. ACS Appl Mater Interfaces 6:8729–8743
Liu J, Wang P, Chu C-C, Xi T (2017) A novel biodegradable and biologically functional arginine-based poly (ester urea urethane) coating for Mg–Zn–Y–Nd alloy: enhancement in corrosion resistance and biocompatibility. J Mater Chem B 5:1787–1802
Logeart D, Prigent-Richard S, Jozefonvicz J, Letourneur D (1997) Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization. Eur J Cell Biol 74:376–384
Lu P, Fan H, Liu Y, Cao L, Wu X, Xu X (2011) Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents. Colloids Surf B 83:23–28
Luo L, Wang G, Li Y, Yin T, Jiang T, Ruan C (2011) Layer-by-layer assembly of chitosan and platelet monoclonal antibody to improve biocompatibility and release character of PLLA coated stent. J Biomed Mater Res Part A 97:423–432
Mani G, Torres N, Oh S (2011) Paclitaxel delivery from cobalt-chromium alloy surfaces using self-assembled monolayers. Biointerphases 6:33–42
Mariano E, Sangiorgi GM, Fioranelli M (2013) Coronary stents. In: Imaging coronary arteries. Springer, New York, pp 101–113
del Valle Martín EM, Galan MA, Carbonell RG (2009) Drug delivery technologies: the way forward in the new decade. Indus Eng Chem Res 48:2475–2486
McGinty S, McKee S, McCormick C, Wheel M (2014) Release mechanism and parameter estimation in drug-eluting stent systems: analytical solutions of drug release and tissue transport. Math Med Biol 32(2):163–186
Middleton JC, Tipton A (1998) Synthetic biodegradable polymers as medical devices. Med Plast Biomater 5:30–39
Morice M-C et al (2006) Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial. EuroIntervention 2:45–52
Morie A, Garg T, Goyal AK, Rath G (2016) Nanofibers as novel drug carrier—an overview. Artif Cells Nanomed Biotechnol 44:135–143
Muramatsu T, Onuma Y, García-García HM, Farooq V, Bourantas CV, Morel MA, Li X, Veldhof S, Bartorelli A, Whitbourn R, Abizaid A, Serruys PW, ABSORB-EXTEND Investigators (2013) Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORBEXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv 6(3):247–257
Nakafuku C, Takehisa SY (2004) Glass transition and mechanical properties of PLLA and PDLLA-PGA copolymer blends. J Appl Polym Sci 93:2164–2173
Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, Kolodgie FD, Virmani R (2008) Drug-eluting stent safety: findings from preclinical studies. Expert Rev Cardiovasc Therapy 6:1379–1391
Nam K, Watanabe J, Ishihara K (2004) Modeling of swelling and drug release behavior of spontaneously forming hydrogels composed of phospholipid polymers. Int J Pharm 275:259–269
Naseem R, Zhao L, Liu Y, Silberschmidt VV (2017) Experimental and computational studies of poly-l-lactic acid for cardiovascular applications: recent progress. Mech Adv Mater Modern Process 3:13
Navarese EP et al (2014) Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. Atherosclerosis 233:224–231
Nebeker JR et al (2006) Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47:175–181
Nguyen TY, Liew CG, Liu H (2013) An in vitro mechanism study on the proliferation and pluripotency of human embryonic stems cells in response to magnesium degradation. PLoS One 8:e76547
Niinomi M (2003) Recent research and development in titanium alloys for biomedical applications and healthcare goods. Sci Technol Adv Mater 4:445
Nio Y et al (1993) Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice. Cancer 72:3599–3606
Nobuyoshi M et al (1988) Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 12:616–623
Nuhn H, Blanco CE, Desai TA (2017) Nanoengineered stent surface to reduce in-stent restenosis in vivo. ACS Appl Mater Interfaces 9:19677–19686
Oberhauser JP, Hossainy S, Rapoza RJ (2009) Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention 5:F15–F22
Onuma Y, Serruys PW (2011) Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123:779–797
Ormiston JA, Webster MW, Armstrong G (2007) First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-l-lactic acid everolimus-eluting coronary stent. Catheter Cardiovasc Interv 69:128–131
Ormiston JA et al (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899–907
Orr AW, Hastings NE, Blackman BR, Wamhoff BR (2010) Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res 47:168–180
Otsuka Y, Chronos N, Apkarian RP, Robinson KA (2007) Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. J Invasive Cardiol 19:71–76
Palmaz JC (1993) Intravascular stents: tissue-stent interactions and design considerations. AJR Am J Roentgenol 160:613–618
Palmaz JC et al (1987) Normal and stenotic renal arteries: experimental balloon-expandable intraluminal stenting. Radiology 164:705–708
Peng T, Gibula P, Goosen MF (1996) Role of polymers in improving the results of stenting in coronary arteries. Biomaterials 17:685–694
Ping P, Wang W, Chen X, Jing X (2005) Poly (ε-caprolactone) polyurethane and its shape-memory property. Biomacromol 6:587–592
Popat A, Hartono SB, Stahr F, Liu J, Qiao SZ, Lu GQM (2011) Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers. Nanoscale 3:2801–2818
Pourdjabbar A, Hibbert B, Simard T, Ma X, O’Brien RE (2011) Pathogenesis of neointima formation following vascular injury. Cardiovasc Haematol Disord Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders) 11:30–39
Prendergast P, Lally C, Daly S, Reid A, Lee T, Quinn D, Dolan F (2003) Analysis of prolapse in cardiovascular stents: a constitutive equation for vascular tissue and finite-element modelling. J Biomech Eng 125:692–699
Pulapura S, Kohn J (1992) Tyrosine-derived polycarbonates: backbone-modified “pseudo”-poly (amino acids) designed for biomedical applications. Biopolymers 32:411–417
Pulapura S, Li C, Kohn J (1990) Structure-property relationships for the design of polyiminocarbonates. Biomaterials 11:666–678
Puricel S et al (2015) Comparison of everolimus-and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. J Am Coll Cardiol 65:791–801
Qi P, Maitz MF, Huang N (2013) Surface modification of cardiovascular materials and implants. Surf Coat Technol 233:80–90
Qi Y et al (2017) Strategy of metal–polymer composite stent to accelerate biodegradation of iron-based biomaterials. ACS Appl Mater Interfaces 10:182–192
Rab ST, King SB, Roubin GS, Carlin S, Hearn JA, Douglas JS (1991) Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents. J Am Coll Cardiol 18:1524–1528
Regar E, Sianos G, Serruys P (2001) Stent development and local drug delivery. Br Med Bull 59:227–248
Rensing B et al (2001) Coronary restenosis elimination with a sirolimus eluting stent; First European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur Heart J 22:2125–2130
Rosenholm JM, Zhang J, Sun W, Gu H (2011) Large-pore mesoporous silica-coated magnetite core-shell nanocomposites and their relevance for biomedical applications. Microporous Mesoporous Mater 145:14–20
Saleh YE, Gepreel MA, Allam NK (2017) Functional nanoarchitectures for enhanced drug eluting stents. Sci Rep 7:40291
Santos M, Bilek M, Wise S (2015) Plasma-synthesised carbon-based coatings for cardiovascular applications. Biosurf Biotribol 1:146–160
Schatz RA et al (1991) Clinical experience with the Palmaz-Schatz coronary stent. J Am Coll Cardiol 17:155–159
Schierbeck LL et al (2012) Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 345:e6409
Schmidt W, Lanzer P, Behrens P, Topoleski L, Schmitz KP (2009) A comparison of the mechanical performance characteristics of seven drug-eluting stent systems. Catheter Cardiovas Interv 73:350–360
Schwach-Abdellaoui K, Heller J, Gurny R (1999) Hydrolysis and erosion studies of autocatalyzed poly (ortho esters) containing lactoyl–lactyl acid dimers. Macromolecules 32:301–307
Serruys PW et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489–495
Serruys PW et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897–910
Serruys PW, Garcia-Garcia HM, Onuma Y (2011a) From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33:16–25
Serruys PW et al (2011b) Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol 58:1578–1588
Sharkawi T, Cornhill F, Lafont A, Sabaria P, Vert M (2007) Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents. J Pharm Sci 96:2829–2837
Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and re-stenosis after transluminal angioplasty. N Engl J Med 316:701–706
Sigwart U, Urban P, Golf S, Kaufmann U, Imbert C, Fischer A, Kappenberger L (1988) Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation 78:1121–1127
Simard T, Hibbert B, Ramirez FD, Froeschl M, Chen Y-X, O’Brien ER (2014) The evolution of coronary stents: a brief review. Can J Cardiol 30:35–45
Staubli A, Mathiowitz E, Lucarelli M, Langer R (1991) Characterization of hydrolytically degradable amino acid containing poly (anhydride-co-imides). Macromolecules 24:2283–2290
Stone GW et al (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294:1215–1223
Tamada J, Langer R (1992) The development of polyanhydrides for drug delivery applications. J Biomater Sci Polym Edit 3:315–353
Tamai H et al (2000) Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 102:399–404
Tan A, Alavijeh MS, Seifalian AM (2012) Next generation stent coatings: convergence of biotechnology and nanotechnology. Trends Biotechnol 30:406–409
Tan A et al (2013) Surface modification of a polyhedral oligomeric silsesquioxane poly (carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells. Biointerphases 8:23
Tanguay JF, Zidar J, Phillips H 3rd, Stack R (1994) Current status of biodegradable stents. Cardiol Clin 12:699–713
Thiruppathi E, Mani G (2014) Vitamin-c delivery from cocr alloy surfaces using polymer-free and polymer-based platforms for cardiovascular stent applications. Langmuir 30:6237–6249
Tortoriello A, Pedrizzetti G (2004) Flow-tissue interaction with compliance mismatch in a model stented artery. J Biomech 37:1–11
Tsujino I, Ako J, Honda Y, Fitzgerald PJ (2007) Drug delivery via nano-, micro and macroporous coronary stent surfaces. Expert Opin Drug Deliv 4:287–295
Tugtekin SM, Kappert U, Jung F, Park J-W, Knaut M (2004) Do drug-eluting stents influence the spectrum of coronary artery bypass surgery? Herz 29:201
Uygun BE, Stojsih SE, Matthew HW (2009) Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. Tissue Eng Part A 15:3499–3512
van Beuskeom H, Vander Giessen W, Serruys P, Kutryk M (2000) Coronary stent coatings (Appendix E) handbook of coronary stents, 3rd edn. Martin Dunitz Ltd, London, pp 403–419
van der Giessen WJ, van Beusekom HM, van Houten CD, van Woerkens LJ, Verdouw PD, Serruys PW (1992) Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Coron Artery Dis 3:631–640
Van Der Giessen WJ et al (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94:1690–1697
Van Dijk M, Tunc D, Smit T, Higham P, Burger E, Wuisman P (2002) In vitro and in vivo degradation of bioabsorbable PLLA spinal fusion cages. J Biomed Mater Res 63:752–759
Venkatraman SS, Tan LP, Joso JFD, Boey YCF, Wang X (2006) Biodegradable stents with elastic memory. Biomaterials 27:1573–1578
Venkatraman S, Boey YC, Khanolkar L (2018) U.S. Patent No. 9,987,399. U.S. Patent and Trademark Office, Washington, DC
Vert M (1989) Bioresorbable polymers for temporary therapeutic applications. Macromol Mater Eng 166:155–168
Vert M, Li S, Spenlehauer G, Guérin P (1992) Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci 3:432–446
Vieira A, Vieira J, Ferra J, Magalhães F, Guedes R, Marques A (2011) Mechanical study of PLA–PCL fibers during in vitro degradation. J Mech Behav Biomed Mater 4:451–460
Virmani R et al (2004a) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Circulation 109:701–705
Virmani R, Kolodgie FD, Farb A (2004b) Drug-eluting stents: are they really safe? Am Heart Hosp J 2:85–88
Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VSY (2010) Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 6:1952–1967
Vorpahl M, Finn AV, Nakano M, Virmani R (2009) The bioabsorption process: tissue and cellular mechanisms and outcomes. EuroIntervention 5:F28. https://doi.org/10.4244/EIJV5IFA5
Waksman R (2006) Biodegradable stents: they do their job and disappear. J Invasive Cardiol 18:70–74
Waksman R, Pakala R, Baffour R, Seabron R, Hellinga D, Tio FO (2008) Short-term effects of biocorrodible iron stents in porcine coronary arteries. J Interv Cardiol 21:15–20
Wang H et al (2013a) Biofunctionalization of titanium surface with multilayer films modified by heparin-VEGF-fibronectin complex to improve endothelial cell proliferation and blood compatibility. J Biomed Mater Res Part A 101:413–420
Wang Y, Zhang W, Zhang J, Sun W, Zhang R, Gu H (2013b) Fabrication of a novel polymer-free nanostructured drug-eluting coating for cardiovascular stents. ACS Appl Mater Interfaces 5:10337–10345
Wayangankar SA, Ellis SG (2015) Bioresorbable stents: is this where we are headed? Prog Cardiovasc Dis 58:342–355
Wessely R et al (2005) Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol 25:748–753
Wiebe J, Nef HM, Hamm CW (2014) Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol 64:2541–2551
Wiemer M, Butz T, Schmidt W, Schmitz KP, Horstkotte D, Langer C (2010) Scanning electron microscopic analysis of different drug eluting stents after failed implantation: from nearly undamaged to major damaged polymers. Catheter Cardiovasc Interv 75:905–911
Witte F (2015) Reprint of: the history of biodegradable magnesium implants: a review. Acta Biomater 23:S28–S40
Wong HM, Yeung KW, Lam KO, Tam V, Chu PK, Luk KD, Cheung KM (2010) A biodegradable polymer-based coating to control the performance of magnesium alloy orthopaedic implants. Biomaterials 31:2084–2096
Wu F, Li J, Zhang K, He Z, Yang P, Zou D, Huang N (2015) Multifunctional coating based on hyaluronic acid and dopamine conjugate for potential application on surface modification of cardiovascular implanted devices. ACS Appl Mater Interfaces 8:109–121
Yakacki CM, Shandas R, Lanning C, Rech B, Eckstein A, Gall K (2007) Unconstrained recovery characterization of shape-memory polymer networks for cardiovascular applications. Biomaterials 28:2255–2263
Yamawaki T et al (1998) Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 32:780–786
Yang X, Manninen H, Matsi P, Soimakallio S (1991) Percutaneous endovascular stenting: development, investigation and application. Eur J Radiol 13:161–173
Yang Z, Tu Q, Wang J, Huang N (2012) The role of heparin binding surfaces in the direction of endothelial and smooth muscle cell fate and re-endothelialization. Biomaterials 33:6615–6625
Yang C-S, Wu H-C, Sun J-S, Hsiao H-M, Wang T-W (2013) Thermo-induced shape-memory PEG-PCL copolymer as a dual-drug-eluting biodegradable stent. ACS Appl Mater Interfaces 5:10985–10994
Yang Y et al (2014) Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response. ACS Appl Mater Interfaces 6:14608–14620
Yang Y et al (2015) A biocompatible and functional adhesive amine-rich coating based on dopamine polymerization. J Mater Chem B 3:72–81
Yu S, Gao Y, Mei X, Ren T, Liang S, Mao Z, Gao C (2016) Preparation of an arg-glu-asp-val peptide density gradient on hyaluronic acid-coated poly (ε-caprolactone) film and its influence on the selective adhesion and directional migration of endothelial cells. ACS Appl Mater Interfaces 8:29280–29288
Zhang L et al (2008) Fabrication and size-selective bioseparation of magnetic silica nanospheres with highly ordered periodic mesostructure. Adv Func Mater 18:3203–3212
Zhang J et al (2012) Magnetic mesoporous silica nanospheres as DNA/drug carrier. Mater Lett 67:379–382
Zhou Z et al (2010) Biological evaluation of poly-l-lactic acid composite containing bioactive glass. Polym Bull 65:411–423
Zhou Z et al (2014) Fabrication of 3D TiO2 micromesh on silicon surface and its effects on platelet adhesion. Mater Lett 132:149–152